Determining the Prevalence of Hepatitis Delta Virus, Hepatitis C Virus, and HIV Among Mothers and Infants with Hepatitis B Virus Chronic Infection

2Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Background: Infection with hepatitis B, C, and delta viruses (HBV/HCV/HDV) caused by mother-to-child transmission (MTCT) is still a serious health problem worldwide. Coinfection with HBV/HDV or HCV has been shown to accelerate the progression of chronic HBV infection, resulting in higher mortality. Objectives: The aim of this study was to evaluate the prevalence of anti-HCV, anti-HDV, and anti-HIV antibodies in mothers with chronic HBV infection and their infants. Methods: This cross-sectional study was performed on 100 mothers with chronic HBV (hepatitis B surface antigen-positive [HBsAg+ ]/hepatitis B core antibody-positive [HBcAb+ ]) and their infants between 2020 and 2021 in northeastern Iran. The presence of serological markers of HBV, anti-HCV, anti-HDV, and HIV antibodies, as well as the liver function tests, were evaluated in all mothers. The obtained data were analyzed using SPSS version 20, and the level of the statistical significance was set at a P-value < 0.05. Results: The mean age in all individuals was 37.45 ± 17.95 years. In mothers with chronic HBV and their infants, 3%, 11%, and 15% were serologically positive for anti-HCV, HCV/HDV, and anti-HDV, respectively. Also, all participants were serologically negative for anti-HIV. A statistical analysis showed a significant correlation of anti-HDV (95% CI, 0.113-0.332) with education, place of residence, and anti-HCV (95% CI, 0.313-0.416) in mothers with chronic HBV. The percentages of mothers and infants with simultaneous infection HBV were reported to be 1%, 2%, and 1% when anti-HCV, anti-HDV, and anti-HCV/HDV antibodies were measured, respectively. Conclusions: Intellectual strategies in the diagnosis of HCV, HIV, and HDV in patients with chronic HBV have challenged public and global health, and preventing viral infections in newly born infants is the most effective way to control the HBV/HCV or HDV epidemic.

References Powered by Scopus

The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level results from the global burden of disease study 2015

1598Citations
N/AReaders
Get full text

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

1450Citations
N/AReaders
Get full text

Prevalence and burden of HCV co-infection in people living with HIV: A global systematic review and meta-analysis

566Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Mutations in the S gene of hepatitis B virus in three generations of patients with chronic hepatitis B

4Citations
N/AReaders
Get full text

Clinical and virological aspects of core and pre-core mutations in three generations of chronic hepatitis B virus patients

2Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Naderi, M., Hosseini, S. M., Behnampour, N., Shahramian, I., & Moradi, A. (2022). Determining the Prevalence of Hepatitis Delta Virus, Hepatitis C Virus, and HIV Among Mothers and Infants with Hepatitis B Virus Chronic Infection. Jundishapur Journal of Microbiology, 15(7). https://doi.org/10.5812/jjm-127879

Readers over time

‘22‘23‘2402468

Readers' Seniority

Tooltip

Professor / Associate Prof. 1

25%

Lecturer / Post doc 1

25%

PhD / Post grad / Masters / Doc 1

25%

Researcher 1

25%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

40%

Biochemistry, Genetics and Molecular Bi... 1

20%

Nursing and Health Professions 1

20%

Social Sciences 1

20%

Save time finding and organizing research with Mendeley

Sign up for free
0